State of Wisconsin Investment Board’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,999
Closed -$221K 2492
2023
Q1
$221K Buy
+17,999
New +$293K ﹤0.01% 2218

Other funds holding PRME

State of Wisconsin Investment Board's PRME Position: Q2 2023 in Review

State of Wisconsin Investment Board sold out of Prime Medicine (PRME) in Q2 2023, closing a stake of 17,999 shares — an estimated $221K sold.

State of Wisconsin Investment Board first reported a position in PRME in Q1 2023 and held it in 1 quarter. The position peaked at $221K in Q1 2023. 79 funds tracked by Wall St. Rank hold PRME as of Q2 2023.

  • State of Wisconsin Investment Board reported no remaining Prime Medicine position as of Q2 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 17,999 Prime Medicine shares in Q2 2023, an estimated $221K.
  • State of Wisconsin Investment Board first reported a position in Prime Medicine in Q1 2023 and held it in 1 quarter.
  • State of Wisconsin Investment Board's Prime Medicine position peaked at $221K in Q1 2023.
  • 79 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2023, filed 14 Aug 2023.